Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
(Dapagliflozin + zibotentan) by AstraZeneca for Proteinuria: Likelihood of Approval
(Dapagliflozin + zibotentan) is under clinical development by AstraZeneca and currently in Phase III for Proteinuria. According to GlobalData, Phase...
(Dapagliflozin + zibotentan) by AstraZeneca for Liver Cirrhosis: Likelihood of Approval
(Dapagliflozin + zibotentan) is under clinical development by AstraZeneca and currently in Phase II for Liver Cirrhosis. According to GlobalData,...
(Dapagliflozin + zibotentan) by AstraZeneca for Chronic Kidney Disease (Chronic Renal Failure): Likelihood of Approval
(Dapagliflozin + zibotentan) is under clinical development by AstraZeneca and currently in Phase III for Chronic Kidney Disease (Chronic Renal...